Search Results - "Kurz, Emma"
-
1
The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL
Published in Nature (London) (01-10-2019)“…Bacterial dysbiosis accompanies carcinogenesis in malignancies such as colon and liver cancer, and has recently been implicated in the pathogenesis of…”
Get full text
Journal Article -
2
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
Published in Cancer discovery (01-04-2018)“…We found that the cancerous pancreas harbors a markedly more abundant microbiome compared with normal pancreas in both mice and humans, and select bacteria are…”
Get more information
Journal Article -
3
EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion
Published in Cell (06-01-2022)“…Non-small cell lung cancers (NSCLCs) harboring KEAP1 mutations are often resistant to immunotherapy. Here, we show that KEAP1 targets EMSY for…”
Get full text
Journal Article -
4
Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy
Published in Cell reports (Cambridge) (24-08-2021)“…Tumor genotype can influence the immune microenvironment, which plays a critical role in cancer development and therapy resistance. However, the immune effects…”
Get full text
Journal Article -
5
Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer
Published in Cancer cell (11-07-2022)“…Aerobic exercise is associated with decreased cancer incidence and cancer-associated mortality. However, little is known about the effects of exercise on…”
Get full text
Journal Article -
6
PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer
Published in Nature immunology (01-04-2020)“…Programmed cell death protein 1 (PD-1) ligation delimits immunogenic responses in T cells. However, the consequences of programmed cell death 1 ligand 1…”
Get full text
Journal Article -
7
Innate αβ T-Cells Mediate Anti-Tumor Immunity by Orchestrating Immunogenic Macrophage Programming
Published in Journal of the American College of Surgeons (01-10-2019)Get full text
Journal Article -
8
Exploration of Mechanisms that Govern Tumorigenesis and Anti-tumor Immunity in Pancreatic Cancer
Published 01-01-2022“…This thesis work will approach the topic of pancreatic ductal adenocarcinoma (PDA) intractability in two distinct parts. The first chapter (Chapter 1; Pages…”
Get full text
Dissertation -
9
Abstract LT005: Tumor-intrinsic gain of function p53R172H mutation drives accumulation of neutrophils in the pancreatic tumor microenvironment that promotes resistance to immunotherapy
Published in Cancer research (Chicago, Ill.) (01-03-2021)“…Abstract KRASG12D mutations in tumor cells can modify the immune microenvironment of pancreatic ductal adenocarcinoma (PDAC), though the effects of secondary…”
Get full text
Journal Article -
10
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
Published in Cancer cell (12-11-2018)“…Pancreatic ductal adenocarcinoma (PDA) is characterized by immune tolerance and immunotherapeutic resistance. We discovered upregulation of…”
Get full text
Journal Article -
11
Abstract PR-005: Tumor intrinsic p53 mutation drives accumulation of neutrophils in the pancreatic tumor microenvironment promoting resistance to immunotherapy
Published in Cancer research (Chicago, Ill.) (15-11-2020)“…Abstract Intratumoral genetic alterations can cause remodeling of local immune cell populations through distinct cellular mechanisms. After oncogenic KRAS,…”
Get full text
Journal Article -
12
Systems‐Based Analysis of the Pancreatic Cancer‐Specific Glycome Reveals ST6GAL1 as a Driver of Human and Murine Disease
Published in The FASEB journal (01-05-2021)“…Pancreatic ductal adenocarcinoma (PDA) is the 3rd leading cause of cancer‐death in the U.S.. Glycans, such as CA‐19‐9, are biomarkers of PDA, but their roles…”
Get full text
Journal Article -
13
Integrated Systems Analysis of the Murine and Human Pancreatic Cancer Glycomes Reveals a Tumor-Promoting Role for ST6GAL1
Published in Molecular & cellular proteomics (2021)“…Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer death in the United States. Glycans, such as carbohydrate antigen 19-9, are…”
Get full text
Journal Article -
14
γδ T Cells Promote Steatohepatitis by Orchestrating Innate and Adaptive Immune Programming
Published in Hepatology (Baltimore, Md.) (01-02-2020)“…Background and Aims The recruitment and activation of inflammatory cells in the liver delineates the transition from hepatic steatosis to steatohepatitis (SH)…”
Get full text
Journal Article -
15
Epigenetic silencing of the ubiquitin ligase subunit FBXL7 impairs c-SRC degradation and promotes epithelial-to-mesenchymal transition and metastasis
Published in Nature cell biology (01-09-2020)“…Epigenetic plasticity is a pivotal factor that drives metastasis. Here, we show that the promoter of the gene that encodes the ubiquitin ligase subunit FBXL7…”
Get full text
Journal Article -
16
Breast Density in a Contemporary Cohort of Women With Ductal Carcinoma In Situ (DCIS)
Published in Annals of surgical oncology (01-10-2019)“…Background Mammographic breast density (MBD) is an independent risk factor for breast cancer. Information regarding the relationship of MBD and breast cancer…”
Get full text
Journal Article -
17
Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis
Published in Oncogene (01-06-2019)“…Liver fibrosis and fibrosis-associated hepatocarcinogenesis are driven by chronic inflammation and are leading causes of morbidity and death worldwide. SYK…”
Get full text
Journal Article -
18
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
Published in Cancer cell (12-10-2020)Get full text
Journal Article -
19
Abstract 6142: Gain-of-function p53R172H mutation drives accumulation of neutrophils in the pancreatic tumor microenvironment promoting resistance to immunotherapy
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract The immune microenvironment plays a critical role in cancer development, progression and resistance to therapy. Specific tumor genotypes can…”
Get full text
Journal Article -
20
Non-BRCA hereditary gene mutations and breast cancer phenotype: An ISC-RAM Consortia study
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article